How Airway Obstruction and Respiratory Distress Can Impact Pediatric Patients Versus Adult Patients With Congenital Plasminogen Deficiency

News
Video

Pharmacy Times® interviewed Charles Nakar, MD and Amy Shapiro, MD, of the Indiana Hemophilia & Thrombosis Center, on how airway obstruction and respiratory distress can impact pediatric patients versus adult patients.

Pharmacy Times® interviewed Charles Nakar, MD and Amy Shapiro, MD, both pediatric hematologist-oncologists at the Indiana Hemophilia & Thrombosis Center, on their presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses research into acute airway obstruction in 4 pediatric patients with congenital plasminogen deficiency treated with intravenous plasminogen replacement therapy under an expanded access protocol.

In this video, Nakar and Shapiro explain how airway obstruction and respiratory distress can impact pediatric patients versus adult patients, and whether there are unique considerations for the treatment of pediatric patients.

Related Videos
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
Opill manufacturing | Perrigo
Healthy food selection - Image credit: Alexander Raths | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.